Consolidated Statements of Comprehensive Loss Parentheticals - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Consolidated Statements of Operations [Abstract]
Stock-based compensation expense associated with research and development expense	$ 1,203	$ 1,032
Stock-based compensation expense associated with selling, general and administrative expense	$ 2,212	$ 1,740